2025-10-08 • globenewswire.com
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity
2025-10-08 • globenewswire.com
Fractyl Health Announces Potent Preclinical Results from RJVA-002, a Dual GIP/GLP-1 Gene Therapy Candidate for Obesity2 minutes ago • globenewswire.com
U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations8 minutes ago • globalconstructionreview.com
US shutdown will hurt construction, contractors warn22 minutes ago • globallegalchronicle.com
ICD Updates Trust Certificate Programme and Completes $500 Million Sukuk Issuance25 minutes ago • fuelcellsworks.com
Motorsport’s Hydrogen Dream Becomes a Reality in Qiddiya39 minutes ago • biospace.com
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences41 minutes ago • prnewswire.co.uk
Alkagesta UK: driving biofuels growth and investment strategy from London41 minutes ago • prnewswire.co.uk
Diesel Generator Market 2030 Outlook Shows Growth Led by Industrialization & Infrastructure Expansion | Global Industry Worth USD 34.63B, Reports Mordor Intelligence41 minutes ago • newswire.ca
Deloitte Canada's Holiday Retail Outlook Shows Spending Expected to Rise by 3%43 minutes ago • farmersreviewafrica.com
Ethiopia launches innovative pay-as-you-go tractor financing to accelerate agricultural mechanization54 minutes ago • steelorbis.com
BIR: Global recycled steel market sees brief stability before demand weakens59 minutes ago • tctmagazine.com
Cummings Aerospace using 3D printing to rapidly iterate Hellhound S3 drone3 hours ago • fintechmagazine.com
Mastercard Tackles Fraud with Digital Identity Tech2 minutes ago • globenewswire.com
U.S. Food and Drug Administration Awards Year Two Proceeds from Orphan Products Grant Supporting Palvella Therapeutics’ Phase 3 SELVA Trial of QTORIN™ Rapamycin for Microcystic Lymphatic Malformations3 minutes ago • reinsurancene.ws
AXIS Capital appoints Erik Rasmussen as Head of US Healthcare Reinsurance3 minutes ago • rttnews.com
CTNM Eyes Q4 Data From PIPE-307 MS Trial; PIPE-791 Advances Toward IPF Proof-Of-Concept39 minutes ago • media-outreach.com
SIBUR Reports 88% Completion of Amur Gas Chemical Complex3 minutes ago • thehindubusinessline.com
Chandan Healthcare board approves ₹104 crore fund raise via preferential issue10 minutes ago • theprint.in
Railway Minister reviews construction of Bilimora Station on Mumbai-Ahmedabad Bullet Train project11 minutes ago • constructionworld.in
Saya Group, Harmony Infra to Build Rs 16 billion Luxury Project10 minutes ago • EIN Presswire
Barcodetrade Deploys CO2 Calculator to Track Green Benefits of Reutilised AIDC Hardware10 minutes ago • EIN Presswire
Vagus Nerve Stimulation Market Set to Surge to US$1,013.4 Mn by 2032 – Persistence Market Research11 minutes ago • constructionmanagement.co.uk
TBM Elizabeth completes HS2’s final Birmingham tunnelStay ahead with real-time headlines from top sources, categorized by sector and country.